Advanced Biomed Inc. Common Stock (ADVB) vs Medicus Pharma Ltd. Common Stock (MDCX)

A side-by-side comparison of Advanced Biomed Inc. Common Stock and Medicus Pharma Ltd. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Advanced Biomed Inc. Common Stock logo
ADVB
Advanced Biomed Inc. Common Stock
$9M
$6.75HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT
Medicus Pharma Ltd. Common Stock logo
MDCX
Medicus Pharma Ltd. Common Stock
$10M
$0.16HealthcareDelayed quote: Oct 6, 2026, 12:52 PM EDT

Total return — ADVB vs MDCX

growth of $100 · dividends reinvested · last 2y
ADVB -91.3% (-70.5%/yr)MDCX -94.5% (-76.4%/yr)ADVB compounded faster over this window
050100150200250Start $1002026$9$6
ADVB MDCX

ADVB vs MDCX: by the numbers

  • •MDCX is the larger company ($10M vs $9M market cap).

Metrics side by side

Valuation

MetricADVBMDCX
P/B ratio1.01N/A

Profitability

MetricADVBMDCX
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROE-7.36%N/A
ROIC-11.06%-269.16%

Go deeper

Full ADVB analysisFull MDCX analysisInteractive comparison tool

Dig into the metrics

Advanced Biomed Inc. Common Stock ROEMedicus Pharma Ltd. Common Stock ROEAdvanced Biomed Inc. Common Stock operating marginMedicus Pharma Ltd. Common Stock operating marginAdvanced Biomed Inc. Common Stock revenue growthMedicus Pharma Ltd. Common Stock revenue growthAdvanced Biomed Inc. Common Stock free cash flowMedicus Pharma Ltd. Common Stock free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.